| scholarly article | Q13442814 |
| P50 | author | Johan Nuyts | Q45836943 |
| P2093 | author name string | Dequeker J | |
| Bouillon R | |||
| Mortelmans L | |||
| Schiepers C | |||
| Verbruggen A | |||
| De Roo M | |||
| Bormans G | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1970-1976 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET | |
| P478 | volume | 38 |
| Q40707077 | (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. |
| Q37298652 | (18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease |
| Q39041614 | Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning |
| Q53192090 | Age-related changes in pre- and postmenopausal women investigated with 18F-fluoride PET--a preliminary study. |
| Q93014203 | Applications of PET-Computed Tomography-Magnetic Resonance in the Management of Benign Musculoskeletal Disorders |
| Q53620684 | Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET. |
| Q33659824 | Bone healing of severe acetabular defects after revision arthroplasty |
| Q36837314 | Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study |
| Q36847805 | Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis |
| Q36627805 | Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions |
| Q92377555 | Compartmental-modelling-based measurement of murine glomerular filtration rate using 18F-fluoride PET/CT |
| Q37261280 | Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT. |
| Q39607583 | Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients |
| Q53192686 | Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images. |
| Q50785762 | Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[(18)F]fluoro-D-glucose ( (18)F-FDG) and (18)F-fluoride. |
| Q38611187 | Imaging and evaluation of patients with high-risk prostate cancer. |
| Q38244363 | Imaging of site specific bone turnover in osteoporosis using positron emission tomography |
| Q53637813 | Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures. |
| Q44644862 | In vivo measurements of blood flow and bone metabolism in osteoarthritis |
| Q64080491 | Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of F-Fluoride Metabolic Flux Than with Measurement of F-Fluoride PET/CT SUV? |
| Q57758848 | Is there still a role for SPECT–CT in oncology in the PET–CT era? |
| Q33617175 | Magnetically targeted viral envelopes: a PET investigation of initial biodistribution |
| Q35203602 | Molecular Mechanisms of Bone 18F-NaF Deposition |
| Q57026125 | PET-MRI for the Study of Metabolic Bone Disease |
| Q60652348 | PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers’ pharmacokinetics |
| Q35095297 | Parametric Images in Assessing Bone Grafts Using Dynamic F-Fluoride PET |
| Q37301288 | Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). |
| Q37570051 | Potential of PET-MRI for imaging of non-oncologic musculoskeletal disease. |
| Q41180773 | Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma |
| Q53198094 | Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women. |
| Q52654951 | Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. |
| Q34642993 | Sodium 18F-fluoride PET/CT of bone, joint, and other disorders |
| Q36290002 | The role of 18F-NaF PET/CT in metastatic bone disease |
| Q34776666 | The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model |
| Q39342954 | Therapy assessment of bone metastatic disease in the era of 223radium. |
| Q84937940 | ¹⁸F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy |
Search more.